Q: Why has M42 chosen to expand its presence in Saudi Arabia now?
A: For over a decade, M42 has been a trusted healthcare partner to the Kingdom through our renal care network, Diaverum, which operates more than 40 clinics across 33 Saudi cities, including in Riyadh, Jeddah, Makkah and Madinah. This long-standing collaboration has given us deep local experience and a strong appreciation for Saudi Arabia’s health transformation journey.

The incorporation of M42 Saudi Arabia represents a natural next step for us, underlining our commitment to the people of Saudi Arabia and our ambition to build on our long-standing partnership with the Saudi Ministry of Health (MoH) to further contribution to the Kingdom’s Vision 2030 healthcare transformation agenda. While continuing with the provision of renal care, we see huge opportunities for collaboration in advancing patient care, multi-omics, population health programs, and cutting-edge AI and digital transformation. M42’s expansion in Saudi Arabia is about investing, partnering and supporting the next chapter of Saudi Arabia’s health transformation journey, accelerating the shift to precision, preventive and predictive, and creating a health system that is sustainable, future facing and locally and globally impactful.

Q: How does this move fit within Saudi Arabia’s Vision 2030 and broader healthcare goals?

A: At the heart of Saudi Arabia’s Vision 2030 lies the Health Sector Transformation Program, which is redefining global benchmarks in healthcare transformation. It shifts focus from reactive treatment to preventive, data-driven, and patient-centered care, which perfectly aligns with M42’s model, expertise and track record.

Through M42 Saudi Arabia, we will bring our global expertise in advanced patient care, multi-omics capabilities and digital health solutions to complement the Kingdom’s investments in healthcare infrastructure and innovation. Most importantly, we are determined to do it by working with and cultivating local talent and expertise. Together, we aim to accelerate the shift toward preventive and future-ready health systems, enhance clinical efficiency, and improve long-term outcomes for the Saudi people. Our approach is rooted in partnership and knowledge transfer, ensuring that the innovation we bring directly supports Saudi-led progress.

Q: What areas of collaboration will M42 Saudi Arabia prioritize?

A: M42 operates over 480 facilities in 27 countries, and in recent months we have built successful partnerships in Jordan, Bahrain and Uzbekistan, where we’re co-developed national digital health, long-term care and genomic programs respectively. In Saudi Arabia, we aim to deliver initiatives designed with and for the Kingdom. Our focus spans a broad spectrum:

1.Provision of renal care, with ongoing digitalization of the service to create a unique, Saudi-integrated platform catering to the needs of patients, from AI-powered tools to tackle chronic kidney disease to predictive analytics, reducing hospitalization rates and increasing dialysis patient longevity.
2.Developing local capabilities in genomics and precision and preventive health, to support early detection and targeted intervention for chronic and genetic conditions, as well as support Saudi Arabia’s life sciences agenda, such as in clinical trials and R&D.
3.Advancing digital health and AI integration in patient care, to improve efficiency and enable data-driven clinical decisions across care settings.
4.Empowering Saudi talent by training and employing local professionals across clinical, digital, and analytical roles.
We will also launch Saudi-led R&D initiatives and pilot programs that build on the Kingdom’s strengths in digital infrastructure and innovation. This is about long-term capability-building and enabling Saudi Arabia to progress precision, preventive and predictive healthcare, both regionally and globally.

Q: What differentiates M42 from other healthcare players in the region?

A: M42’s model is unique. We are not a traditional healthcare provider; we combine world-class care delivery with genomics, data science, and AI. This allows us to bring an integrated health intelligence ecosystem that moves healthcare from reactive, episodic sick care to precision, prevention and prediction. Our strength lies in collaboration; we have successfully collaborated with governments across the world to build national-scale health programs and create cutting-edge technologies.

We are bringing that same cooperative spirit and knowledge to Saudi Arabia, supported by a strong local footprint and workforce that already understands the needs of Saudi patients and systems.

Q: What long-term impact does M42 envision in Saudi Arabia?

A: Our ambition is to help shape a sustainable, future-ready health system, combining scientific advancement with human-centered care. By working hand-in-hand with Saudi partners, we hope to make measurable contributions to disease prevention, digital transformation and workforce development.

Our long-term ambition is to co-create sustainable health solutions that serve Saudi communities for generations to come, combining our global expertise with Saudi Arabia’s extraordinary vision and talent.

Ultimately, our success will be defined by the value we create for Saudi patients, professionals and communities. M42 Saudi Arabia supports the Kingdom in achieving its healthcare vision and marks the beginning of a new chapter in a trusted partnership, built on performance, impact and shared purpose.